Pioglitazone And Metformin Hydrocholride
NDC Package 0093-5049-86

View Billable Units, 11-Digit Conversion Format, and RxNorm mappings
Table of Contents
    1. Package Information
    2. Other Packages
    3. Frequently Asked Questions

Package Information

This product is EXCLUDED from the official NDC directory because the listing data was discontinued by the firm.

Pioglitazone And Metformin Hydrocholride is a . Marketed by Teva Pharmaceuticals Usa, this product is identified by NDC 0093-5049 and is authorized under FDA application NDA021842.

Identification & Billing

NDC Package Code
0093-5049-86
Package Description
180 TABLET, FILM COATED in 1 BOTTLE
Product Code
0093-5049
11-Digit Billing Format
00093504986
Billing Unit
EA - Billing unit of "each" is used when the product is dispensed in discreet units.
Units Per Package
180 EA

Clinical Specifications

Proprietary Name
Pioglitazone And Metformin Hydrocholride
Dosage Form
-

Regulatory & Marketing

Labeler Name
Teva Pharmaceuticals Usa
FDA Application #
NDA021842
Marketing Category
NDA AUTHORIZED GENERIC - A product marketed as a "generic" drug under an approved New Drug Application (NDA), rather than an Abbreviated New Drug Application (ANDA),.
Start Marketing Date
08-17-2012
End Marketing Date
01-31-2018
Listing Expiration
01-31-2018
Exclude Flag
D
Sample Package
No

Hierarchy Structure

Code Lineage

The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.

* Please review the full disclaimer at the bottom of this page.

Other Available Packages

The following commercial packages are registered under the same Product NDC (0093-5049). Click a package code to view its specific billing and regulatory data.

0093-5049-06
60 TABLET, FILM COATED in 1 BOTTLE

* Please review the full disclaimer at the bottom of this page.

Frequently Asked Questions

What is the distribution configuration for this product package?

The code 0093-5049-86 identifies a specific commercial package of 180 tablet, film coated in 1 bottle of Pioglitazone And Metformin Hydrocholride, labeled by Teva Pharmaceuticals Usa. This is formulated for use and contains as the active substance.

Is this product currently listed with the FDA?

This product code is currently listed as inactive or excluded from the primary directory. It was introduced to the market by Teva Pharmaceuticals Usa on August 17, 2012. The current certification is valid through January 31, 2018.

How is this Teva Pharmaceuticals Usa product billed for insurance claims?

For medical billing and reimbursement, this package follows the 11-digit CMS format: 00093504986. Quantities are measured in per "each", products billed on a per each basis are usually products dispensed in discreet units.. There are 180 total billable units per package. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.

11-Digit Code Conversion

Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:

10-Digit Format (4-4-2)
0093-5049-86
11-Digit CMS (5-4-2)
00093-5049-86

Note: The zero is added to the Labeler segment to maintain the 5-4-2 structure.